- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: advanced level
- Also shares: premium pricing
Back to StakeholdersHarvard University University of Pennsylvania IPI Alex Criddle
Categories
2 domains / 4 areas / 3 specializations
University of Wisconsin-Madison
Data updated
United States
10 Trials
The University of Wisconsin-Madison Transdisciplinary Center for Research in Psychoactive Substances is dedicated to exploring the scientific, historical, and cultural aspects of psychoactive substances, focusing on psychedelics.
AdvancedOnlinePremiumAcademic programmeContinuing educationResearchersLicensed cliniciansAspiring practitionersOther
Blossom’s read
University of Wisconsin-Madison sits at the serious, academic end of the psychedelic education field. Its offer is strongest for people who want a rigorous, science-led pathway into psychoactive substances, with clear links to pharmacy, research ethics, history, and therapeutic application. The flagship route carries real institutional weight, with teaching from active clinicians and researchers and a curriculum that reaches beyond pharmacology into the humanities as well.
Who is University of Wisconsin-Madison for?
Best for graduates and working professionals who want an academically grounded route into psychedelic or psychoactive-substance research, drug development, or adjacent healthcare and policy roles. It is especially suited to people with a science, pharmacy, medicine, psychology, law, history, bioethics, or related background.
What do you need before you start?
For the MS, applicants need a bachelor’s degree from an accredited institution or equivalent, a background in a relevant field, a minimum 3.0 undergraduate GPA, English proficiency if applicable, and at least three college-level science courses totalling 9 or more credits. The programme also states that students enrolled in the MS may not accept assistantships or other university appointments that waive tuition or academic fees.
Is University of Wisconsin-Madison accredited?
The university describes the Master of Science in Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation as the first accredited degree focusing on the study and therapeutic application of psychedelic compounds and related psychoactive drugs. UW-Madison Continuing Education also states that its programmes can qualify for professional continuing education in several Wisconsin and national contexts, including APA approval for psychologists and recognised credit for certain Wisconsin licences.
How much does it cost?
The MS tuition is published at $1,500 per credit, with 30 graduate credits listed for the degree. The university says scholarships are available, and the programme may also be eligible for Federal Student Aid. The capstone certificate is positioned as a rapid, non-degree alternative, but the page does not publish a single total programme price.
What do you walk away with?
Learners can expect an accredited MS or a graduate-level capstone certificate, depending on route. The curriculum builds knowledge in psychedelic pharmacology, drug development, regulatory practice, screening and guiding practices around therapeutic sessions, and critical appraisal of clinical research, with pathways towards pharmaceutical, academic, government, non-profit, and healthcare roles.
Academic Research
0 papersPublished Papers
0
Trial Involvement
10
Distinct Focus Topics
0
Latest Publication
Unknown
Government funding received
1 grantARPA-H EVIDENT — Conscious vs non-conscious mechanisms of psilocybin therapy
2025
Part of the ARPA-H EVIDENT Initiative (total $139.4M, ≥$50M earmarked for psychedelic research for serious mental illness). UW-Madison contributes data from 3 approved psilocybin trials to dissociate the contributions of conscious psychedelic experience and non-conscious neurobiological mechanisms. Amount is an editorial estimate — funder has not published per-team award amounts; TO BE CONFIRMED.
SourceSimilar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 2 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: advanced level
- Also shares: premium pricing
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: online delivery
- Also shares: premium pricing
- Strong match: 2 shared modalities
- Strong match: 4 shared learner audiences
- Also shares: online delivery
- Also shares: same country: United States
Quick Facts
- Type
- academic
- Founded
- 1848
- HQ
- United States
- Website
- Visit
Research Landscape
What the 10 registered trials University of Wisconsin-Madison sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
How fast is University of Wisconsin-Madison research growing?
SourcedRegistered trials by recorded study-start year. Click a year for the running total.
Don't read as total research effort: only registered trials with a recorded start date are counted (10 of 10 tracked). Recent years under-count because of registration lag; striped bars are still filling in or are planned starts.
What's live right now, and what stopped?
SourcedRegistry status of all 10 University of Wisconsin-Madison trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.